Post Profile

Study Identifies New Therapeutic Target in Non-Hodgkin's Lymphoma

Researchers have discovered that an enzyme called uracil-DNA glycosylase (UNG) protects the ends of B cell chromosomes to facilitate the proliferation of these antibody-producing cells in response to infection. The study "UNG protects B cells from AID-induced telomere loss," which will be published online October 3 ahead of issue in The Journal of Experimental Medicine, also suggests that targeting this enzyme may help treat certain types of non-Hodgkin's lymphoma.
read more


Related Posts

Study Reveals How Key Protein Protects Against Viral Infections

Health : Newswise Medical News

Scientists from the University of Utah have discovered that a mouse protein called IFITM3 contributes to defense against some types of viral infections by binding to an enzyme responsible for regulating the pH of a cell's waste disp...

Enzyme That Finds Unwanted DNA In Cells Revealed

Health : Medical News Today

Two new studies published in Nature recently reveal the structure and mechanism of an enzyme called cGAS that detects DNA found in the wrong place inside mammal cells and triggers an immune response. The researchers believe their fi...

Study of antibody evolution charts course toward HIV vaccine

Health : Medical News Today

In an advance for HIV vaccine research, a scientific team has discovered how the immune system makes a powerful antibody that blocks HIV infection of cells by targeting a site on the virus called V1V2. Many researchers believe that ...

Adcetris (Brentuximab Vedotin) Approved For Hodgkin Lymphoma And Systemic Anaplastic Large Cell Lymphoma - FDA

Health : Medical News Today

The FDA has approved brentuximab vedotin, brand name Adcetris, for the treatment of HL (Hodgkin lymphoma) and ALCL (systemic anaplastic large cell lymphoma). Adcetris consists of a drug and an antibody - an antibody-drug conjugate -...

Potential Target To Arrest Cancer Cell Growth Suggested By Chromosome Shortening Findings

Health : Medical News Today

A team of scientists at the Salk Institute for Biological Studies has identified why disruption of a vital pathway in cell cycle control leads to the proliferation of cancer cells. Their findings on telomeres, the stretches of DNA a...


Copyright © 2016 Regator, LLC